Oncology Voice Network
Join the Oncology Voice Network. Join for Free
Gratitude: An absolute MUST for career advancement
gratitude in professional relationships career growth for MSLs compliance and gratitude expressing appreciation methods gratitude as career advancement tool

Gratitude: An absolute MUST for career advancement

  • Nov 23rd 2021
  • 23 mins
  • E80

Share This Article

Summary

In this special solo episode, Tom Caravela, Founder of The Carolan Group, delves into the essential role of gratitude within professional relationships and career growth for MSLs. He discusses the compliance aspects and the benefits of integrating gratitude into daily communications, emphasizing its impact on emails and post-meeting interactions. Tom shares creative methods for expressing appreciation and highlights annual gratitude practices to make it a consistent habit. Throughout the episode, he underscores gratitude as a crucial factor for career advancement, concluding with sincere appreciation for the listeners' support.

Tom Caravela discusses why gratitude is an absolute MUST for career advancement.

In this episode we discuss:

  • Good things come from gratitude
  • Connecting to people through gratitude
  • Time is currency
  • Going the extra mile to show others you appreciate them

Click for Source
gratitude in professional relationships, career growth for MSLs, compliance and gratitude, expressing appreciation methods, gratitude as career advancement tool

Related Topics

Explore the Ecosystem

Meet Our Innovation Partners

You May Also Like

Podcast
How to Develop IDPs Individual Development Plans and Road Maps for Career Development
Partner Avatar MSL Talk: Tom Caravela, Elaine Nadeau

How to Develop IDPs Individual Development Plans and Road Maps for Career Development

Nov 3rd • 37 mins • listen
Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Apr 26th • 15 mins • read
Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Apr 16th • 28 mins • listen
Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Apr 13th • 10 mins • read
Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Dec 2nd • 2 mins • read
Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Nov 20th • 12 mins • read

Explore OVN

Articles Expert-written insights
Browse Ecosystem Oncology focus areas
OVN Podcast Flagship show
Community Why join OVN